Long-term kidney outcomes after new-onset type 2 diabetes in adults with preserved kidney function and no albuminuria: a nationwide cohort study

Introduction Type 2 diabetes is the leading cause of end-stage kidney disease (ESKD), yet long-term trajectories of kidney function from the time of diagnosis‐particularly in individuals with preserved kidney function and no albuminuria‐remain poorly characterized. We aimed to evaluate the long-term risks of incident albuminuria and kidney function decline and to characterize the heterogeneity of early disease progression in adults with newly diagnosed type 2 diabetes. Methods Using the Korean National Health Insurance Service database, we identified 226,265 individuals newly diagnosed with type 2 diabetes in 2012‐2013 and 678,795 matched non-diabetic controls. The primary outcome was a composite kidney outcome (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2, incident albuminuria, dialysis, or kidney transplantation). Trajectory-based clustering was employed to identify distinct patterns of eGFR decline in the type 2 diabetes cohort. Results Over a median 9.1-year follow-up, 12.9% of patients with type 2 diabetes experienced the composite kidney outcome versus 9.4% of controls (absolute risk difference, 3.5%). Type 2 diabetes was associated with higher risks of the composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.18-1.22), incident albuminuria (aHR, 1.45; 95% CI, 1.40–1.50), and dialysis or kidney transplantation (aHR, 2.98; 95% CI, 2.59–3.43). Despite the modest mean difference in annual eGFR decline (–0.03 mL/min/1.73 m2/year), trajectory-based clustering revealed substantial heterogeneity. Approximately one-third of patients showed a progressive eGFR decline. Conclusions Although the average annual eGFR decline in newly diagnosed type 2 diabetes was modestly greater than that in the general population, the absolute cumulative risk of the composite kidney outcome was meaningfully higher over long-term follow-up. Substantial heterogeneity in eGFR trajectories suggests that average measures mask high-risk subgroups, highlighting the need for early monitoring and proactive kidney-protective strategies from diagnosis.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-18
DOI
https://doi.org/10.3389/fendo.2026.1944422
Primary Topic
Chronic Kidney Disease and Diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-term kidney outcomes after new-onset type 2 diabetes in adults with preserved kidney function and no albuminuria: a nationwide cohort study

Seok‐Jae Heo, Hyung Woo Kim, Sang Youb Han, Hyun Jung Kim et al.
2 links
Frontiers in Endocrinology
Chronic Kidney Disease and Diabetes
article

Long-term kidney outcomes after new-onset type 2 diabetes in adults with preserved kidney function and no albuminuria: a nationwide cohort study

Seok‐Jae Heo, Hyung Woo Kim, Sang Youb Han, Hyun Jung Kim, Samel Park, Sun-Hee Park
article en

Abstract

Introduction Type 2 diabetes is the leading cause of end-stage kidney disease (ESKD), yet long-term trajectories of kidney function from the time of diagnosis‐particularly in individuals with preserved kidney function and no albuminuria‐remain poorly characterized. We aimed to evaluate the long-term risks of incident albuminuria and kidney function decline and to characterize the heterogeneity of early disease progression in adults with newly diagnosed type 2 diabetes. Methods Using the Korean National Health Insurance Service database, we identified 226,265 individuals newly diagnosed with type 2 diabetes in 2012‐2013 and 678,795 matched non-diabetic controls. The primary outcome was a composite kidney outcome (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m2, incident albuminuria, dialysis, or kidney transplantation). Trajectory-based clustering was employed to identify distinct patterns of eGFR decline in the type 2 diabetes cohort. Results Over a median 9.1-year follow-up, 12.9% of patients with type 2 diabetes experienced the composite kidney outcome versus 9.4% of controls (absolute risk difference, 3.5%). Type 2 diabetes was associated with higher risks of the composite outcome (adjusted hazard ratio [aHR], 1.20; 95% CI, 1.18-1.22), incident albuminuria (aHR, 1.45; 95% CI, 1.40–1.50), and dialysis or kidney transplantation (aHR, 2.98; 95% CI, 2.59–3.43). Despite the modest mean difference in annual eGFR decline (–0.03 mL/min/1.73 m2/year), trajectory-based clustering revealed substantial heterogeneity. Approximately one-third of patients showed a progressive eGFR decline. Conclusions Although the average annual eGFR decline in newly diagnosed type 2 diabetes was modestly greater than that in the general population, the absolute cumulative risk of the composite kidney outcome was meaningfully higher over long-term follow-up. Substantial heterogeneity in eGFR trajectories suggests that average measures mask high-risk subgroups, highlighting the need for early monitoring and proactive kidney-protective strategies from diagnosis.

Frontiers in EndocrinologyVol. 17
Yonsei University (KR), Korea University (KR), Soonchunhyang University (KR), Kyungpook National University (KR), Inje University Ilsan Paik Hospital (KR), Soonchunhyang University Hospital Cheonan (KR), Yonsei University Health System (KR)
Good health and well-being
Chronic Kidney Disease and Diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon